Insights
- All
- Insights
- Solutions
- Uncategorized
Three HPV diagnostic trends powering the achievement of 2030’s targets
The phrase ‘high performance test’ is used regularly when addressing the in vitro diagnostics of human papillomavirus (HPV). Traditional methods of pap smears, acetic acid …
Receptacles, regulations and responsibility: The three Rs of biological sample packaging
When it comes to biological logistics, particularly the handling and transporting of biological specimens, we rely on our own set of principles: the three Rs …
Net Zero targets: Who in the healthcare sector should be concerned?
Did you know that 5 million tonnes of plastic waste comes from hospitals worldwide every year? The NHS alone produces 133,000 tonnes of plastic annually, …
RDi announces CEO appointment
LONDON – June 25 2024 – RDi, the leading provider of healthcare and pharma services solutions for patient sample collection, today announced the appointment of …
RDi joins the NHS’ North West London Pathology
RDi joins the NHS’ North West London Pathology as a proud sponsor of the upcoming NWLP Symposium taking place in June 2024, to unite and …
Help or hindrance: Home diagnostic kits transform diagnostic laboratory data
As each at-home medical device gradually becomes more complex and intuitive than its predecessor, home diagnostic kits and testing have become a ground-breaking advancement in …
Streamlining Healthcare Supply Chains: Simplifying Specimen Packaging and Transport
In today’s rapidly evolving healthcare landscape, efficient and reliable management of sample collection and specimen packaging and transport is critical.
The rise of the at-home HPV test
International HPV Awareness Day serves a crucial educational purpose, emphasising the importance of early diagnosis and highlighting its direct association with cervical cancer.
The healthcare sector is on the cusp of revolutionising HPV and cervical cancer diagnosis and management. Our technology and capabilities put us at the forefront of next-generation HPV diagnostics, piloting early diagnosis through the design, distribution, and ongoing management of at-home HPV testing kits.
Exclusive: LDC-backed RDi completes double acquisition
LDC-backed RDi, an automated, data-led healthcare fulfilment specialist, has acquired two companies: MedDX, which deals with diagnostic sample transport, and Shuttlepac, which handles biological sample packaging, this publication can reveal.
The acquisitions have broadened RDi’s portfolio of healthcare kitting and component capabilities.
Everything you need to know about the 2024 NCI cervical cancer initiative
Cervical screenings were put in place in the 1960’s as an essential tool to collect and test abnormal precancer cervix cells.
The next generation of sample collection kits: the future is automation
Within our ever-evolving global landscape, automation has long served as a trusted companion to modern society. Initially assisting within simple and repetitive workflows, the integration of data-led automation is now used to streamline complex and critical processes, improving efficiency, advancing data management and transforming production workflows.
